Share:
The Liver Meeting, organised by the American Association for the Study of Liver Diseases, was held as a hybrid event from 4 to 8 November 2022.
Here are highlights in the field of chronic hepatitis B research:
- Positive data for bepirovirsen from B-Clear phase IIb trial presented at American Association for the Study of Liver Diseases’ Meeting with simultaneous publication in the New England Journal of Medicine
- Vaccitech provides update on ongoing VTP-300 Phase 1b/2a trial showing sustained reductions of HBsAg in patients with chronic hepatitis B
- Vir Biotechnology presents new data evaluating the potential for VIR-2218 and VIR-3434 to achieve a functional cure for chronic hepatitis B virus (HBV) infection
- Aligos Therapeutics presents clinical data for its capsid assembly modulator, ALG-000184, at AASLD’s The Liver Meeting® 2022
- Aligos Therapeutics presents clinical data for its NASH program and nonclinical data for its chronic hepatitis B portfolio at AASLD’s The Liver Meeting® 2022
- Assembly Biosciences presents new data at AASLD The Liver Meeting® highlighting breadth of virology portfolio and potential of next-generation core inhibitors in HBV
- Asher Bio presents new data demonstrating preclinical proof-of-concept for AB359, a highly selective CD8-targeted IL-2 therapy, for chronic hepatitis B (HBV) at AASLD 2022
- MedPage Today: Tenofovir, vaccine combo eliminates mom-to-child HBV transmission
Related HIV and Co-Infections News
-
Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences
-
EurekAlert!: Between 2.4 and 4.1 million people estimated to be living with chronic hepatitis B infection in Europe
-
The Rockefeller University: A new mouse model of virus-driven liver cancer may open the door to better diagnosis and treatments
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.